MUST READS

An October 25, 2016 Alzheimer’s News Today article reported that “A treatment that uses microscopic droplets of fat – called nanoliposomes – to carry drugs to the brain has  been used effectively to target cancer cells…has shown promise in restoring memory loss in mice models of Alzheimer’s disease, according to a new study funded by the Alzheimer’s Society.”

An October 24, 2016 The Hill opinion piece by Michelle Sie Whitten, President and CEO of the Global Down Syndrome Foundation, highlighted the potential of studying Down syndrome to advance our understanding of Alzheimer’s. According to Whitten, “While we cannot guess who in the typical population will get Alzheimer’s disease, we can do exactly that in people with Down syndrome and try to understand how to treat the disease early on. Additionally, understanding why up to 30 percent of people with Down syndrome have the brain pathology of Alzheimer’s disease but do not have symptoms such as dementia may help us with diagnostics, therapies, or even a cure.”

An October 24, 2016 Voice of America article reported that “…the results of a new study in Australia show that increased muscle strength can improve brain function in older adults.” 

An October 24, 2016 Genegnews.com article reported that “Scientists from the German Centre for Neurodegenerative Diseases and the DFG-Center for Regenerative Therapies Dresden have identified two proteins, interleukin-4 (IL-4) and STAT6, that appear to play important roles in the Alzheimer’s disease process.”

An October 24, 2016 The Sacramento Bee interview with Cori Bargmann, president of the Chan Zuckerberg Initiative, highlighted the initiative's approach to tackling diseases like Alzheimer’s. According to Bargmann, “We are going to prioritize based on a combination of unmet needs and opportunities. I am a neuroscientist. I can tell you very easily where there are unmet needs in brain disorders. There are a lot of brain disorders where we can’t do anywhere near enough for the people who suffer from them. Not just things like Alzheimer’s, but seizure disorders or autism or schizophrenia.”